Table 2.
Radiobiological Analysis Based on Linear Quadratic Models Corresponding to Figure 6
| Cell | Control | BiONPs | Cis | BC | |
|---|---|---|---|---|---|
| MCF-7 | α | 0.35 ± 0.02 | 0.62 ± 0.13 | 0.62 ± 0.10 | 1.56 ± 0.14 |
| β | 0.00 ± 0.01 | −0.04 ± 0.04 | −0.02 ± 0.03 | −0.16 ± 0.04 | |
| SER | 1.00 | 1.67 | 1.70 | 4.29 | |
| MDA-MB-231 | α | 0.26 ± 0.03 | 0.52 ± 0.07 | 0.44 ± 0.13 | 0.22 ± 0.02 |
| β | 0.08 ± 0.01 | −0.06 ± 0.02 | 0.04 ± 0.04 | 0.29 ± 0.01 | |
| SER | 1.00 | 1.03 | 1.22 | 1.41 | |
| NIH/3T3 | α | 0.12 ± 0.15 | −0.02 ± 0.06 | 0.27 ± 0.10 | 0.59 ± 0.06 |
| β | 0.09 ± 0.06 | 0.10 ± 0.02 | −0.02 ± 0.03 | −0.04 ± 0.02 | |
| SER | 1.00 | 0.77 | 0.66 | 1.65 |
Notes: Control represents radiation treatment only.
Abbreviations: SER, sensitization enhancement ratio; cGy, centigray; BiONPs, bismuth oxide nanoparticles; Cis, cisplatin; BC, the combination of BiONPs and Cis.